125 related articles for article (PubMed ID: 12943944)
41. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
42. The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant.
Jobe PC; Browning RA
Epilepsy Behav; 2005 Dec; 7(4):602-19. PubMed ID: 16169281
[TBL] [Abstract][Full Text] [Related]
43. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
[TBL] [Abstract][Full Text] [Related]
44. Cardiovascular effects of tricyclic antidepressants in childhood asthma: a case series and review.
Wamboldt MZ; Yancey AG; Roesler TA
J Child Adolesc Psychopharmacol; 1997; 7(1):45-64. PubMed ID: 9192541
[TBL] [Abstract][Full Text] [Related]
45. Does lorazepam impair the antidepressant response to nortriptyline and psychotherapy?
Buysse DJ; Reynolds CF; Houck PR; Perel JM; Frank E; Begley AE; Mazumdar S; Kupfer DJ
J Clin Psychiatry; 1997 Oct; 58(10):426-32. PubMed ID: 9375592
[TBL] [Abstract][Full Text] [Related]
46. [Response to serotonergic and noradrenergic antidepressants: a crossover study of fluoxetine and desipramine in patients with first major depression episode].
Ontiveros-Sánchez de la Barquera JA
Gac Med Mex; 2017; 153(6):688-694. PubMed ID: 29206826
[TBL] [Abstract][Full Text] [Related]
47. New developments in the treatment of depression.
Montgomery SA
J Clin Psychiatry; 1999; 60 Suppl 14():10-5; discussion 31-5. PubMed ID: 10408420
[TBL] [Abstract][Full Text] [Related]
48. Predictors of response to amine-specific antidepressants.
Burns RA; Lock T; Edwards DR; Katona CL; Harrison DA; Robertson MM; Nairac B; Abou-Saleh MT
J Affect Disord; 1995 Dec; 35(3):97-106. PubMed ID: 8749837
[TBL] [Abstract][Full Text] [Related]
49. Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients.
Laghrissi-Thode F; Pollock BG; Miller MC; Mulsant BH; Altieri L; Finkel MS
Psychopharmacol Bull; 1995; 31(4):659-63. PubMed ID: 8851637
[TBL] [Abstract][Full Text] [Related]
50. [Antidepressants consumption in the global population in France].
Olié JP; Elomari F; Spadone C; Lépine JP
Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
[TBL] [Abstract][Full Text] [Related]
51. Fluency changes in persons who stutter following a double blind trial of clomipramine and desipramine.
Stager SV; Ludlow CL; Gordon CT; Cotelingam M; Rapoport JL
J Speech Hear Res; 1995 Jun; 38(3):516-25. PubMed ID: 7674643
[TBL] [Abstract][Full Text] [Related]
52. Risk factors for and correlates of poststroke depression following discontinuation of antidepressants.
Fiedorowicz JG; Takezawa K; Robinson RG
J Neuropsychiatry Clin Neurosci; 2007; 19(4):399-405. PubMed ID: 18070842
[TBL] [Abstract][Full Text] [Related]
53. Course and rate of antidepressant response in the very old.
Gildengers AG; Houck PR; Mulsant BH; Pollock BG; Mazumdar S; Miller MD; Dew MA; Frank E; Kupfer DJ; Reynolds CF
J Affect Disord; 2002 May; 69(1-3):177-84. PubMed ID: 12103464
[TBL] [Abstract][Full Text] [Related]
54. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
[TBL] [Abstract][Full Text] [Related]
55. A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
Rudolph RL; Feiger AD
J Affect Disord; 1999 Dec; 56(2-3):171-81. PubMed ID: 10701474
[TBL] [Abstract][Full Text] [Related]
56. Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents.
Leonard HL; Meyer MC; Swedo SE; Richter D; Hamburger SD; Allen AJ; Rapoport JL; Tucker E
J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1460-8. PubMed ID: 8543513
[TBL] [Abstract][Full Text] [Related]
57. A double-blind, comparative study of dothiepin and clomipramine in the treatment of major depressive illness.
Welch CP; Tweed JA; Smithers A; Gostick NK; Raniwalla J
Int J Clin Pract; 1997 Sep; 51(6):360-3. PubMed ID: 9489063
[TBL] [Abstract][Full Text] [Related]
58. Mortality and poststroke depression: a placebo-controlled trial of antidepressants.
Jorge RE; Robinson RG; Arndt S; Starkstein S
Am J Psychiatry; 2003 Oct; 160(10):1823-9. PubMed ID: 14514497
[TBL] [Abstract][Full Text] [Related]
59. Amineptine in the management of the depressive syndromes.
Scarzella L; Scarzella R; Mailland F; Bergamasco B
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):429-39. PubMed ID: 4070645
[TBL] [Abstract][Full Text] [Related]
60. Effect of antidepressants on the course of disability following stroke.
Mikami K; Jorge RE; Adams HP; Davis PH; Leira EC; Jang M; Robinson RG
Am J Geriatr Psychiatry; 2011 Dec; 19(12):1007-15. PubMed ID: 21358384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]